Catalyst Wire Dossier Catalyst Wire Dossier

ZELSUVMI

berdazimer · LNHC, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ZELSUVMI, covering 2024-01-05 to 2024-01-05. Get the full timeline:

Most recent: FDA Approved: ZELSUVMI — Original Application (LNHC, Inc.)

See pricing